Mayo T, Haderlein M, Schuster B, Wiesmüller A, Hummel Ch, Bachl M, Schmidt M, Fietkau R, Distel L. Is in Vivo and Ex Vivo Irradiation Equally Reliable for Individual Radiosensitivity Testing by Three Colour Fluorescence in Situ Hybridization? (2019) Radiation Oncology 15 (1), 2 doi: 10.1186/s13014-019-1444-4 |
Mayo T, Schuster T, Ellmann B, Schmidt M, Fietkau R, Distel L,V. Individual Radiosensitivity in Lung Cancer Patients Assessed by G0 and Three Color Fluorescence in Situ Hybridization (2019) OBM Genetics doi:10.21926/obm.genet.1902082 |
Rate of individuals with clearly increased radiosensitivity rise with age both inhealthy individuals and in cancer patients. (2018) Barbara Schuster, Anna Ellmann, Theresa Mayo, Judith Auer, Matthias Haas, Markus Hecht, Rainer Fietkau, Luitpold V. Distel; BMC Geriatrics 18:105 |
Idelalisib may have the potential to increase radiotherapy side effects (2017) Gryc T, Putz F, Goerig N, Ziegler S, Fietkau R, Distel LV, Schuster B. Radiat Oncol. 12 |
Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients (2015) M. Hecht, L. Zimmer, C. Loquai, C. Weishaupt, R. Gutzmer, B. Schuster, S. Gleisner, B. Schulze, S. M. Goldinger, C. Berking, A. Forschner, P. Clemens, G. Grabenbauer, T. Müller-Brenne, J. Bauch, H. T. Eich, S. Grabbe, D. Schadendorf, G. Schuler, P. Keikavoussi, S. Semrau, R. Fietkau, L. V. Distel & L. Heinzerling; Annals of Oncology 26 p1238–1244 |
NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients (2015) Keller Ulrike , Hecht Markus, Harrer Thomas, Harrer Ellen, Schuster Barbara, Fietkau Rainer, Luitpold V. Distel; Radiotherapy and Oncology 116 p323-30 |
Radiosensitivity increases with age (2016) Schuster B., Hecht M., Hirschmann E., Badura H., Ziegler S., Fietkau R. and Distel L.; Poster Gesellschaft für Biologische Strahlenforschung, Erlangen, 26-28.9.2016 |
Hecht, M Zimmer, L Loquai, C Weishaupt, C Gutzmer, R Schuster, B Gleisner, S Schulze, B Goldinger, SM Berking, C Forschner, A Clemens, P Grabenbauer, G Muller-Brenne, T Bauch, J Eich, HT Grabbe, S Schadendorf, D Schuler, G Keikavoussi, P Semrau, S Fietkau, R Distel, LV Heinzerling, L Radio Sensitization through BRAF Inhibitors- Mechanism and Frequency of Toxicities in Melanoma patients Strahlenther Oncol 191 (2014) S128-S129 |
Schuster, B Ellmann, A Hecht, M Haderlein, M Fietkau, R Distel, L With age Piling up by ex vivo Exposure to complex Chromosomal Aberrations in Lymphocytes Strahlenther Oncol 191 (2014) 91-S91 |
Ellmann, A Soppa, B Haderlein, M Fietkau, R Distel, L Individual Radiosensitivity in Cancer patients Strahlenther Oncol 190 (2014) 88 |
Soppa, B Ellmann, A Hecht, M Merten, R Haderlein, M Filimonova, I Fietkau, R Distel, L Radiosensitivity at old Age Strahlenther Oncol 190 (2014) 141-142 |
Gleisner, S Soppa, B Hecht, M Fietkau, R Distel, L Vemurafenib increases the individual Radiosensitivity in Patients with malignant Melanoma Strahlenther Oncol 191 (2014) S157-S157 |
Ellmann A, Soppa B, Haderlein M, Fietkau, Distel L. Individual differences in chromosomal aberrations in a rectum cancer collective and cancer patients with assumed increased radiosensitivity. Oncol Res Treat 37 (2014) S114 |